Somatic mutations of EGFR gene in squamous cell carcinoma of the head and neck. - Wikidata - awgldk - TriplyDB

Somatic mutations of EGFR gene in squamous cell carcinoma of the head and neck.

Somatic mutations of EGFR gene in squamous cell carcinoma of the head and neck.

http://www.wikidata.org/entity/Q46443613

about

Biomarkers of head and neck cancer, tools or a gordian knot?Protein-intrinsic and signaling network-based sources of resistance to EGFR- and ErbB family-targeted therapies in head and neck cancer Current role of EGF receptor monoclonal antibodies and tyrosine kinase inhibitors in the management of head and neck squamous cell carcinoma Genome stability pathways in head and neck cancers MMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer.Epidermal growth factor receptor and K-RAS status in two cohorts of squamous cell carcinomas Exons 19 and 21 of epidermal growth factor receptor are highly conserved in squamous cell cancer of the head and neck Molecular and clinical responses in a pilot study of gefitinib with paclitaxel and radiation in locally advanced head-and-neck cancer.Aberrations in the epidermal growth factor receptor gene in 958 patients with diverse advanced tumors: implications for therapy.Epidermal growth factor receptor targeted therapy of squamous cell carcinoma of the head and neck Tongue carcinoma infrequently harbor common actionable genetic alterations Combination of phosphorylated and truncated EGFR correlates with higher tumor and nodal stage in head and neck cancer Screening for EGFR Mutations in Patients with Head and Neck Cancer Treated with Gefitinib on a Compassionate-Use Program: A Hellenic Cooperative Oncology Group Study.Dacomitinib, an irreversible Pan-ErbB inhibitor significantly abrogates growth in head and neck cancer models that exhibit low response to cetuximab.EGFR targeting drugs in the treatment of head and neck squamous cell carcinoma.Frequency of EGFR mutations in 907 lung adenocarcioma patients of Indian ethnicity.Receptor-tyrosine-kinase-targeted therapies for head and neck cancer.Effect of erlotinib on epidermal growth factor receptor and downstream signaling in oral cavity squamous cell carcinoma.Monitoring response to gefitinib in nude mouse tumor xenografts by (18)F-FDG microPET-CT: correlation between (18)F-FDG uptake and pathological response.Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma.Mutations in the epidermal growth factor receptor (EGFR) gene in triple negative breast cancer: possible implications for targeted therapy.An Inducible TGF-β2-TGFβR Pathway Modulates the Sensitivity of HNSCC Cells to Tyrosine Kinase Inhibitors Targeting Dominant Receptor Tyrosine Kinases.Part 4: pharmacogenetic variability in anticancer pharmacodynamic drug effects.Opportunities and challenges facing biomarker development for personalized head and neck cancer treatment.A phase II trial of induction chemotherapy and chemo-IMRT for head and neck squamous cell cancers at risk of bilateral nodal spread: the application of a bilateral superficial lobe parotid-sparing IMRT technique and treatment outcomes.A growing family: adding mutated Erbb4 as a novel cancer target Tumor epidermal growth factor receptor and EGFR PY1068 are independent prognostic indicators for head and neck squamous cell carcinoma.Erlotinib is effective in pancreatic cancer with epidermal growth factor receptor mutations: a randomized, open-label, prospective trial EGFR Monoclonal Antibodies in the Treatment of Squamous Cell Carcinoma of the Head and Neck: A View beyond Cetuximab.Role of GRB2-associated binder 1 in epidermal growth factor receptor-induced signaling in head and neck squamous cell carcinoma.Epidermal growth factor receptor mutations predict sensitivity to gefitinib in patients with non-small-cell lung cancer.Epidermal growth factor receptor inhibition and non-small cell lung cancer.Gefitinib (ZD1839, Iressa) as palliative treatment in recurrent or metastatic head and neck cancer Targeting epidermal growth factor receptor signaling in the treatment of head and neck cancer.Cetuximab in the treatment of head and neck cancer.Cheminfomatic-based Drug Discovery of Human Tyrosine Kinase Inhibitors.Molecular profiling of lung carcinoma: identifying clinically useful tumor markers for diagnosis and prognosis.Targeting EGF-receptor-signalling in squamous cell carcinomas of the head and neck.Small molecule signal transduction inhibitors for the treatment of solid tumors.Targeted cancer therapies based on antibodies directed against epidermal growth factor receptor: status and perspectives.

P2860

Q26784289-64437A74-0575-4649-A6D2-4270A1C818D0 Q26852215-05701ED4-EBE0-47BD-A196-4ED8F68654D8 Q26991953-00CC9198-B7B0-4711-A52F-FFC8A35FF65C Q28391355-C90B7FDE-7DDC-42C6-A3DD-770D7028A3B6 Q33570512-D8584B42-2E25-4CF9-BE4C-6FB0CF0CDAB9 Q33575439-E642C4A3-C478-461E-986D-BC0D80018393 Q33621754-838A4627-4A01-4757-9574-74113B572DA8 Q33843578-5B7375F3-BACB-46D7-8B70-38B1C9F96450 Q33947959-CD3A4FF6-FD79-4508-B8B9-F783E67EBF19 Q34159125-7C766E3C-AB28-40E4-9081-EF5AF570B9D8 Q34256064-CC0FE09E-DC89-4C17-B2B5-E95679FE0B2A Q34318204-8C20FEFF-1973-4D2E-AFF4-28F45516D167 Q34497010-0D8B4B95-E91E-4D7C-AD03-B23E20D29342 Q34584728-0A21E944-0FB7-4D3E-BA24-89E21580C936 Q34618994-1834B8ED-1855-484B-93D8-D59D81364D60 Q35016912-60CE86AA-4ED1-45E2-A968-3D92FC1E0489 Q35102025-05119EE8-0B64-43E5-A44E-DF9F15A534D8 Q35191014-A6FDD719-230E-445D-8399-CB4B52720BB8 Q35215449-266FBDD1-A77F-4E95-8561-AA7A2936D9CE Q35471421-ECB79C81-A5E1-4E74-88FD-895CBDAB8637 Q35558988-98F1261B-00AC-4836-BDFD-51B7BE6E8833 Q35577672-1D083DE0-4052-4BAA-B3DE-57006DAC19BC Q35584647-5F04BA8E-0714-4C33-BEAD-F80BF5F1096A Q35673572-A01E145F-10E4-4EF5-B8F6-120E7C5C32AF Q35677705-3098CD21-4C6F-4DC5-8969-D1F000393345 Q36062442-31F3FC15-C868-49CE-BF8D-88F0D3F40610 Q36196817-86BE31F3-D692-4A37-95FB-F3C7A29107B9 Q36228534-0C254BE4-0080-462A-8069-B4109ECF6687 Q36302347-6F6A002E-C5F0-4C9C-9F39-3910B6ADBC84 Q36400027-BCF92511-3D8D-4F9A-9BC2-23F85AB59EE3 Q36429519-2C0AA802-54D2-4AB9-AFC7-BD893F522695 Q36504349-24CF0738-E5AA-4F03-9E90-CF3F7EAFD30F Q36613924-EC9386E1-67F7-4195-8095-D279FD3AC6A0 Q36613969-CA012A93-8F02-4B55-B30B-C5861D3EA91F Q36668224-5C56D77A-FC84-4DEF-B62B-D93EBA18E873 Q36669662-AADEE683-ED93-4B3F-9CCE-B70A073EB508 Q36691733-CD005E1D-2728-425C-BB07-E263DFAEF2AC Q36708974-F2E0876E-039B-48EC-9DF3-688F8E2C5029 Q36895413-4F873C78-211E-4438-A3E1-A852D6163667 Q36920799-90A96C06-7BF2-414A-9A83-3227CF664DB1

P2860

Somatic mutations of EGFR gene in squamous cell carcinoma of the head and neck.

http://www.wikidata.org/entity/Q46443613

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Somatic mutations of EGFR gene in squamous cell carcinoma of the head and neck.

@en

Somatic mutations of EGFR gene in squamous cell carcinoma of the head and neck.

@nl

type

label

Somatic mutations of EGFR gene in squamous cell carcinoma of the head and neck.

@en

Somatic mutations of EGFR gene in squamous cell carcinoma of the head and neck.

@nl

prefLabel

Somatic mutations of EGFR gene in squamous cell carcinoma of the head and neck.

@en

Somatic mutations of EGFR gene in squamous cell carcinoma of the head and neck.

@nl

P1433

Q46443613-64DD1BEE-72C8-4B7B-BF25-20E74760CF2B

P1476

Q46443613-C854291B-8E27-4428-B8AE-89378B32C696

P2093

Q46443613-1CDB96E0-3433-4D09-B4EF-5AEFAA71D0DE

Q46443613-324FFD50-D98F-4BF8-BE5A-69155808CCD2

Q46443613-3CDE80B4-39E3-4779-8A4C-DE8CFEEE7A29

Q46443613-482C6149-2DAB-4BD1-B395-E1546BA709C0

Q46443613-718E58E0-5B05-42DC-903A-4746942D6AC8

Q46443613-790A1BE6-A150-4405-8D6F-FCAE9DBEEDE3

Q46443613-936E4B7F-D95B-4FAE-8615-63EC95271319

Q46443613-9F8AEBE3-2D83-43AA-936A-8C37DFA1473E

Q46443613-AB028E37-5D5A-458C-82AB-CFCF551380EF

Q46443613-E2B05E1C-B312-44F7-8113-C30BFB2AA084

P304

Q46443613-107A8AAA-ACFA-4D68-ABD9-C7842CC3B0D1

P31

Q46443613-4B8EECA1-FFE8-4D57-A962-02BA5848B36A

P356

Q46443613-DA130DA1-4110-4DF1-B1C5-E976D075C7B6

P407

Q46443613-A2699BBB-EF4D-46E7-98BA-A4E00FB8B3BF

P433

Q46443613-D604969B-0E8B-45FE-B35A-4B2A32761C6A

P478

Q46443613-B7CFDC15-B4D6-473B-8CAB-A64A65A19964

P577

Q46443613-50EEB926-6071-4DFC-B887-3114AE96CAF7

P5875

Q46443613-5748CBBF-19C0-4AB1-905D-E65CBE47F74B

P698

Q46443613-75AAFCD5-8BB5-4011-B429-7C02EEEEA123

P356

1078-0432.CCR-04-2029

P1433

Clinical Cancer Research

P1476

Somatic mutations of EGFR gene in squamous cell carcinoma of the head and neck.

@en

P2093

Dong Il Sun

http://www.w3.org/2001/XMLSchema#string

Hyo Kyung Nam

http://www.w3.org/2001/XMLSchema#string

Ja June Jang

http://www.w3.org/2001/XMLSchema#string

Jong Woo Lee

http://www.w3.org/2001/XMLSchema#string

Jung Young Lee

http://www.w3.org/2001/XMLSchema#string

Min Sik Kim

http://www.w3.org/2001/XMLSchema#string

Nam Jin Yoo

http://www.w3.org/2001/XMLSchema#string

Su Young Kim

http://www.w3.org/2001/XMLSchema#string

Sug Hyung Lee

http://www.w3.org/2001/XMLSchema#string

Suk Woo Nam

http://www.w3.org/2001/XMLSchema#string

P304

2879-2882

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-04-2029

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2005-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7898995

http://www.w3.org/2001/XMLSchema#string

P698

15837736

http://www.w3.org/2001/XMLSchema#string